Neurodevelopmental theories of schizophrenia - Preclinical studies;Neurorozwojowe koncepcje schizofrenii - Badania przedkliniczne

Psychiatria Polska

Volumn 37, Issue 4, 2003, Pages 627-639

  Lehner, Małgorzata ^b   Taracha, Ewa ^b   Wisłowska, Aleksandra ^b   Zienowicz, Małgorzata ^b   Maciejak, Piotr ^b   Skórzewska, Anna ^b   Płaźnik, Adam ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b NONE

Author keywords

Deficits in memory and selective attention; Neurodevelopmental model; Neurotransmitter dysfunction

Indexed keywords

AMNESIA; ARTICLE; BASAL GANGLION; BEHAVIOR DISORDER; BRAIN INJURY; CEREBELLUM; DIAGNOSTIC IMAGING; DISEASE MODEL; EMOTION; EXPERIENCE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; NERVE CONDUCTION; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROTRANSMISSION; NEWBORN DISEASE; PATHOPHYSIOLOGY; PERCEPTION; PREFRONTAL CORTEX; RISK FACTOR; SCHIZOPHRENIA; SELECTIVE ATTENTION; TEMPORAL CORTEX; THOUGHT DISORDER;

ADULT; ANIMALS; ANTIPSYCHOTIC AGENTS; CEREBRAL CORTEX; CHILD; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; NEURAL PATHWAYS; PSYCHOLOGICAL THEORY; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0141920609     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bilikiewicz A. Psychozy schizofreniczne. W: Bilikiewicz A, red. Psychiatria. Podrȩcznik dla studentów medycyny, wyd.2. Warszawa: Wydawnictwo Lekarskie PZWL; 1998, s. 233-255.
2. Rang HP, Dale MM, Ritter J. Leki przeciwpsychotyczne W: Wielosz M., red. wyd. pol. Farmakologia kliniczna. Lublin: Wydawnictwo Czelej; 2001, s. 533-543.
3. Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 1986; 43: 114-124.
4. Andreasen NC. Schizophrenia the fundamental questions. Brain Res. Rev. 2000; 31: 106-112.
5. Lipska BK, Weinberger DR: To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacol. 2000; 23: 223-239.
6. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacol. 2002; 27: 47-54.
7. Lipska BK, Halim ND, Segal PN, Weinberger DR. Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J. Neurosc. 2002; 27: 2835-2842.
8. DeHert M, Ellenbroek B. Animal models of schizophrenia. Neurosc. Res. Comm 2000: 26: 279-287.
9. Fijał K. Wpływ blokady receptora NMDA w okresie neonatalnym na zachowanie zwiera̧t dorosłych w eskperymentalnych modelach psychoz. Praca doktorska. Kraków: Instytut Farmakologii PAN; 2002.
10. Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. 1999; 45: 395-402.
11. Egan FE, Weinberger DR. Neurobiology of schizophrenia. Curr. Opinion Neurobiol. 1997; 7: 701-707.
12. Deanen EW, Van der Heyden JA, Kruse CG, Wolterink G, Van Ree JM. Adaptation and habituation to an open field and responses to various atressful events in animals with neonatal lesions in the amygdala or ventral hippcampus. Brain Res. 2001; 918: 153-165.
13. Berretta S, Munno DW, Benes FM. Amygdalar activation alres the hippocampal GABA system: 'Partial ' modelling for post mortem changes in schizophrenia. J. Comp. Neurol. 2001; 431: 129-138.
14. Akbarian S, Bunney WE, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe od schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 1993; 50: 169-177.
15. Thompson PM, Sower AC, Perrone-Bizzozero NI. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol. Psychiatry 1998; 43: 239-243.
16. Lieberman JA, Sheitman BB, Ki non BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacol. 1997; 17: 205-229.
17. Deutsch SI, Rosse RB, Schwartz BL, Mastrpaolo J. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clin. Neuropharmacol. 2001; 24: 43-49.
18. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR, Lewis DA. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 1999; 156: 1580-1589.
19. Semba J, Tanaka N, Wakuta M, Suhara T. Neonatal phencyclidyne treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain. Synapse 2001; 40; 11-18.
20. Al-Amin HA, Weinberger DR, Lipska BK. Exaggerated MK-8012-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behav. Pharmacol. 2000; 11: 269-278.
21. Grauer SM, Marqius KL. Intracembral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dowley rats. Psychopharmacol. 1999; 405-412.
22. Ohnuma T, Augood SJ, Arai H, McKenna PJ, Emson PC. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Mol. Brain Res. 1998; 56: 207-217.
23. Blum BP, Mann JJ. The GABAergic system in schizophrenia. Int. J. Neuropsychopharmacol. 2002; 5: 159-179.
24. Nocjar C, Roth BL, Pehek EA. Localization of 5-HT (2A) receptors on dopamine cells in subnuclei of the midbrain A 10 cell group. Neurosc. 2002; 11: 163-176.
25. Stahl SM. Paying attention to your acetylocholine, part 2. The function of nicotinic receptors. J. Clin. Psychiatry 2000; 61: 628-629.
26. Dawe GS, Huff KD, Vandergriff JL, Sharp T, O'Neill MJ, Rasmussen K. Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biol. Psychiatry 2001; 50: 510-520.
27. Javitt DC, Zukin SR. Recent advances in the phencyklidyne model of schizophrenia. Am. J. Psychiatry 1991; 149: 1301-1308.
28. Bochenek A, Reicher M. Anatomia człowieka. Warszawa: Pafistwowy Zakład Wydawnictw Lekarskich, PZWL; 1981, s. 23-47.
29. Gorter JA, De Bruin JP. Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat. Brain Res. 1992; 580: 12-17.
30. O'Donnell P, Lewis BL, Weinberger DR. Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. 2002; 12: 975-982.
31. Le Pen G, Moreau JL. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacol. 2002; 27: 1-11.
32. Sams-Dodd F, Lipska B, Weinberger DR. Neonatal lesions of the rat ventral hippcampus result in hyperlocomotion and deficits in social behavior in adulthood. Psychopharmacol. 1997; 132: 303-310